2.00
0.05 (2.56%)
0.05 (2.56%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aclaris Therapeutics Inc | ACRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.05 | 2.56% | 2.00 | 1.82 | 2.14 | 1.90 | 1.95 | 00:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.00 | 4.12 | 2.12 | 51.46% | 1 | 1 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,360 | 469,181 | $ 2.02 | $ 948,913 | 882,261 | 0.70 - 4.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:15 | formt | 300 | $ 2.00 | USD |
Aclaris Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 83.73M | 41.87M | 39.82M | $ 12.98M | $ - | -3.90 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aclaris Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACRS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.28 | 2.34 | 1.82 | 2.10 | 383,487 | -0.28 | -12.28% |
| 1 Month | 1.88 | 3.34 | 1.82 | 2.26 | 913,202 | 0.12 | 6.38% |
| 3 Months | 1.31 | 4.99 | 1.20 | 1.86 | 755,505 | 0.69 | 52.67% |
| 6 Months | 1.33 | 4.99 | 0.70 | 1.62 | 541,624 | 0.67 | 50.38% |
| 1 Year | 1.07 | 4.99 | 0.70 | 1.54 | 909,687 | 0.93 | 86.92% |
| 3 Years | 26.72 | 28.93 | 0.70 | 6.56 | 586,111 | -24.72 | -92.51% |
| 5 Years | 11.94 | 33.88 | 0.70 | 9.07 | 420,711 | -9.94 | -83.25% |
Aclaris Therapeutics Description
| Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively. |
